Genetic basis of bilateral renal cancer: implications for evaluation and management.
Linehan
W Marston
WM
D002292:Carcinoma, Renal Cell / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics* / Q000628:therapy; D020022:Genetic Predisposition to Disease; D006801:Humans; D007055:Iceland / Q000453:epidemiology; D015994:Incidence; D007680:Kidney Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics* / Q000628:therapy; D018231:Leiomyomatosis / Q000235:genetics; D009154:Mutation; D009378:Neoplasms, Multiple Primary / Q000453:epidemiology / Q000235:genetics; D016609:Neoplasms, Second Primary / Q000453:epidemiology / Q000235:genetics; D009664:Norway / Q000453:epidemiology; D010235:Paraganglioma / Q000235:genetics; D010673:Pheochromocytoma / Q000235:genetics; D011518:Proto-Oncogene Proteins / Q000235:genetics; D013385:Succinate Dehydrogenase / Q000235:genetics; D013548:Sweden / Q000453:epidemiology; D014402:Tuberous Sclerosis / Q000235:genetics; D025521:Tumor Suppressor Proteins / Q000235:genetics; D006623:von Hippel-Lindau Disease / Q000235:genetics
C476078:FLCN protein, human; D011518:Proto-Oncogene Proteins; D025521:Tumor Suppressor Proteins; C108095:SDHB protein, human; D013385:Succinate Dehydrogenase